Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Luis J. Serrano"'
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 142, Iss , Pp 112059- (2021)
Deficiency of factor V is a congenital autosomal recessive coagulopathy associated with mutations in the F5 gene that results in mild-to-severe bleeding episodes. Factor V is a component of the prothrombinase complex responsible for accelerating conv
Externí odkaz:
https://doaj.org/article/f1e97dea4a914ddc9a91a9fbd0f97c4c
Autor:
Sara Bernal, Irene Pelaez, Laura Alias, Manel Baena, Juan A. De Pablo-Moreno, Luis J. Serrano, M. Dolores Camero, Eduardo F. Tizzano, Ruben Berrueco, Antonio Liras
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 18, p 9705 (2021)
Factor V is an essential clotting factor that plays a key role in the blood coagulation cascade on account of its procoagulant and anticoagulant activity. Eighty percent of circulating factor V is produced in the liver and the remaining 20% originate
Externí odkaz:
https://doaj.org/article/449daf1392784d4c9addd052b0cf5e7b
Autor:
Irene Pelaez, Antonio Liras, Juan Andres De Pablo-Moreno, Eduardo F. Tizzano, M. Dolores Camero, Luis J. Serrano, Sara Bernal, Laura Alias, Rubén Berrueco, Manel Baena
Publikováno v:
International Journal of Molecular Sciences
E-Prints Complutense. Archivo Institucional de la UCM
instname
International Journal of Molecular Sciences, Vol 22, Iss 9705, p 9705 (2021)
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Volume 22
Issue 18
Scientia
E-Prints Complutense. Archivo Institucional de la UCM
instname
International Journal of Molecular Sciences, Vol 22, Iss 9705, p 9705 (2021)
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Volume 22
Issue 18
Scientia
Factor V is an essential clotting factor that plays a key role in the blood coagulation cascade on account of its procoagulant and anticoagulant activity. Eighty percent of circulating factor V is produced in the liver and the remaining 20% originate
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 142, Iss, Pp 112059-(2021)
E-Prints Complutense. Archivo Institucional de la UCM
instname
E-Prints Complutense. Archivo Institucional de la UCM
instname
Deficiency of factor V is a congenital autosomal recessive coagulopathy associated with mutations in the F5 gene that results in mild-to-severe bleeding episodes. Factor V is a component of the prothrombinase complex responsible for accelerating conv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db64daf9788c918c6046d211c9b65a5d
https://eprints.ucm.es/id/eprint/70213/
https://eprints.ucm.es/id/eprint/70213/
Advanced therapies hold substantial promise for the treatment of periodontal conditions. Gene therapy has the potential to transfer “therapeutic” genes, which express proteins such as bone morphogenetic proteins, osteoprotegerin, and tissue nonsp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4b8511ad78bfa980259cdcb64807038
http://www.intechopen.com/articles/show/title/gene-and-cell-therapy-in-dental-tissue-regeneration
http://www.intechopen.com/articles/show/title/gene-and-cell-therapy-in-dental-tissue-regeneration
Autor:
Luis J. Serrano-Tamayo
Publikováno v:
Proceedings of The 3rd International Conference on Advanced Research in Education, Teaching and Learning.
Autor:
Paz de la Torre, Ana I. Flores, Laura Tomás-Gallardo, María José Sánchez, Luis J. Serrano, Tamara Garcia-Leal, Ana Cañete, Antonio Liras
Publikováno v:
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Consejo Superior de Investigaciones Científicas (CSIC)
Digital.CSIC. Repositorio Institucional del CSIC
instname
The development of new strategies based on cell therapy approaches to correct haemophilia A (HA) requires further insights into new cell populations capable of producing coagulation factor VIII (FVIII) and presenting stable engraftment potential. The